Anti-Tumor Effects after Adoptive Transfer of IL-12 Transposon-Modified Murine Splenocytes in the OT-I-Melanoma Mouse Model

• Daniel L. Galvan ,

  Contributed equally to this work with: Daniel L. Galvan, Richard T. O’Neil

  Affiliation Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, United States of America

  ⨯
• Richard T. O’Neil ,

  Contributed equally to this work with: Daniel L. Galvan, Richard T. O’Neil

  Affiliation Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America

  ⨯
• Aaron E. Foster,

  Affiliation Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, United States of America

  ⨯
• Leslie Huye,

  Affiliations Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, United States of America, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States of America

  ⨯
• Adham Bear,

  Affiliation Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, United States of America

  ⨯
• Cliona M. Rooney,

  Affiliations Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, United States of America, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States of America

  ⨯
• Matthew H. Wilson

  * E-mail: matthew.wilson@vanderbilt.edu

  Affiliations Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, United States of America, Tennessee Valley Health Care, Department of Veterans Affairs, Nashville, Tennessee, United States of America, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America

  ⨯